(22761190), F. M. C., (22761193), Y. B., (22761196), R. S. N., (22761199), R. D., (22761202), S. R. P., (22761205), R. d. G. H., . . . (18100116), B. A. W. (2025). Supplementary Table S3 from Combined Inactivation of MEK and mTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal Subtype.
Cita Chicago Style (17a ed.)(22761190), Fleur M.G. Cornelissen, et al. Supplementary Table S3 from Combined Inactivation of MEK and MTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal Subtype. 2025.
Cita MLA (9a ed.)(22761190), Fleur M.G. Cornelissen, et al. Supplementary Table S3 from Combined Inactivation of MEK and MTOR Can Lead to Synergistic Cell Death in Glioblastoma Models and Associates with NF1 Deficiency and a Mesenchymal Subtype. 2025.